Functional Signatures Revealed By Deep Phenotyping of CMV-Specific CD8+T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation

被引：0
|
作者：
Camargo, Jose F.
Wieder, Eric
Kimble, Erik
Benjamin, Cara
Kolonias, Despina
Bravo, Gabriela
Komanduri, Krishna
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
746
引用
收藏
页数：3
相关论文
共 50 条
  • [21] MESENCHYMAL STROMAL CELLS INHIBIT PROLIFERATION OF CMV-SPECIFIC CD8+T CELLS
    Malcherek, G.
    Jin, N.
    Wuchter, P.
    Diehlmann, A.
    Schmitt, A.
    Dreger, P.
    Ho, A. D.
    Michael, S.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S192 - S192
  • [22] Effect of donor regulatory T-cells on CMV-specific CD8+T lymphocytes reconstitution and acute GvHD after allogeneic haematopoietic stem cell transplantation
    Pastore, D.
    Delia, M.
    Mestice, A.
    Carluccio, P.
    Rossi, A. Russo
    Ricco, A.
    Giordano, A. M.
    Cazzato, L.
    Liso, V.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S127 - S127
  • [23] Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT
    B Pourgheysari
    K P Piper
    A McLarnon
    J Arrazi
    R Bruton
    F Clark
    M Cook
    P Mahendra
    C Craddock
    P A H Moss
    Bone Marrow Transplantation, 2009, 43 : 853 - 861
  • [24] Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+and CD8+T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation
    Eid, A. J.
    Brown, R. A.
    Hogan, W. J.
    Lahr, B. D.
    Eckel-Passow, J. E.
    Litzow, M. R.
    Razonable, R. R.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (06) : 519 - 528
  • [25] Analysis of Anti-CMV T-Cell Immunity and CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
    Chen, George
    Zhang, Yali
    Tario, Joseph Dennis
    Herko, Amanda
    Pan, Przespolewski Dalin
    Mellors, Patrick
    Ho, Christine
    Balderman, Sophia R.
    Ross, Maureen
    Brix, Liselotte
    Wallace, Paul K.
    McCarthy, Philip L.
    Hahn, Theresa
    BLOOD, 2017, 130
  • [26] Lack of CMV-specific CD4+ T-cell response after allogeneic stem cell transplantation is a risk factor for CMV organ manifestation
    Campe, H
    Gerbitz, A
    Kolb, H
    Koszinowski, U
    Jäger, G
    BONE MARROW TRANSPLANTATION, 2006, 37 : S31 - S32
  • [27] Poor CMV-specific CD8+T central memory subset recovery at early stage post-HSCT associates with uncontrolled CMV reactivation
    Liu, J.
    Chang, Y. - J.
    Yan, C. -H.
    Xu, L. -P.
    Zhang, X. -H.
    Liu, K. -Y.
    Huang, X. -J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S399 - S400
  • [28] Mesenchymal stem cells can modulate the function of CMV-specific CD8+T cells
    Jin, N.
    Malcherek, G.
    Wuchter, P.
    Diehlmann, A.
    Schmitt, A.
    Ho, A. D.
    Schmitt, M.
    ONKOLOGIE, 2013, 36 : 285 - 285
  • [29] IMMUNE POPULATIONS PREDICT CONTROL OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Diaz-Fernandez, Paula
    Garcia de Soria, Valle Gomez
    Sevilla-Montero, Javier
    Marcos-Jimenez, Ana
    Serra Lopez-Matencio, Jose Maria
    Cardenoso, Laura
    Figuera Alvarez, Angela
    de la Camara, Rafael
    Munoz-Calleja, Cecilia
    BONE MARROW TRANSPLANTATION, 2024, 59 : 431 - 431
  • [30] A Novel CMV-Specific TCR-T Cell Therapy Is Effective and Safe for Refractory CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Cao, Xingyu
    Liu, Guangna
    Zhang, Jianping
    Zhao, Yanli
    Chen, Hua
    Zheng, Hongli
    Rui, Wei
    Jia, Lemei
    Zhao, Xueqiang
    Lin, Xin
    Lu, Peihua
    BLOOD, 2021, 138 : 3848 - +
12345